
News|Articles|June 23, 2026
Pipeline Review: Alzheimer Disease Therapies by Mechanism of Action
Author(s)Louie Pasculli
Fact checked by: Marco Meglio
The 2026 Alzheimer disease drug development landscape highlights a growing shift toward diverse disease-modifying strategies, from amyloid and tau targeting to metabolic and neuroprotective approaches.
Advertisement
Advertisement
June is Alzheimer’s & Brain Awareness Month, an annual observance dedicated to raising awareness of Alzheimer disease (AD), related dementias, and the importance of maintaining brain health across the lifespan. Established by the Alzheimer’s Association in 2014, the campaign highlights the growing burden of AD while promoting education on risk reduction, early detection, diagnosis, and advances in research and treatment.
Related to this article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 13, 2026.

The FDA is requiring new labeling across all GLP-1 receptor agonists to warn of a potential increased risk of a rare, vision-threatening optic nerve condition.

The FDA granted fast track designation to FRP-003, an investigational oral botanical drug candidate for Long COVID, ahead of a planned phase 2 trial evaluating fatigue in approximately 220 adults.

In honor of Veterans Day, Clayton Mucha, DO, neurorehabilitation physiatrist at Burke Rehabilitation in New York, discusses the lasting effects of traumatic brain injury in military personnel.

A study of deceased former NFL players estimated that nearly 75% had CTE neuropathology, while a phase 3 trial is evaluating whether F-18 FNT-PET imaging could help identify disease-associated patterns in living patients.

Darren Gitelman, MD, senior medical director of the Advocate Memory Center in Park Ridge, discusses findings linking high-dose influenza vaccination to lower Alzheimer disease risk, study limitations, and potential implications for future dementia prevention research.

Catch up on any of the neurology headlines you may have missed in October 2026, compiled into 1 place by the NeurologyLive® team.
Advertisement
Advertisement

